Current Report Filing (8-k)
December 08 2021 - 4:40PM
Edgar (US Regulatory)
0001293818
false
0001293818
2021-12-08
2021-12-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
December
8, 2021
Date of Report (date of earliest event reported)
_________________
OpGen, Inc.
(Exact name of Registrant as specified in its charter)
_________________
Delaware
(State or other jurisdiction of incorporation or
organization)
|
|
001-37367
(Commission
File Number)
|
|
06-1614015
(I.R.S. Employer
Identification Number)
|
9717
Key West Ave, Suite 100
Rockville, MD
20850
(Address of principal executive offices)(Zip code)
(240) 813-1260
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_________________
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
OPGN
|
The Nasdaq Capital Market
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 5.07 — Submission of Matters to a
Vote of Security Holders.
On December 8, 2021, OpGen,
Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”). The Company’s stockholders
voted on the proposals listed below, each of which was described in the Company’s proxy statement for the Special Meeting dated
October 29, 2021 (the “Proxy Statement”). At the Special Meeting, a total of 17,520,423 shares of common stock, par value
$0.01 per share, out of a total of 38,950,250 shares of common stock issued and outstanding and entitled to vote, and a total of 150,000
shares of the Company’s Series B Convertible Preferred Stock (the “Preferred Stock”), representing all of the issued
and outstanding shares of Preferred Stock entitled to vote at the Special Meeting, each as of October 19, 2021, the record date for the
Special Meeting, were represented in person or by proxy at the Special Meeting. As previously described in the Proxy Statement, each share
of Preferred Stock entitled the holder to 30,000 votes on each of Proposal 1 and Proposal 2 at the Special Meeting; provided, that, with
respect to Proposal 2, such votes were required to be counted by the Company in the same proportion as the aggregate shares of common
stock were voted on such proposal.
The following is a summary
of the voting results for the proposals voted upon at the Special Meeting:
1.
Proposal 1 – Proposed Amendment to Reduce the Stockholder Vote for Amendments to the Charter.
At the Special Meeting, the Company’s stockholders voted upon and approved the amendment to the Company’s Amended and Restated
Certificate of Incorporation, as amended (the “Charter”), to reduce the stockholder approval requirement for changes to the
Charter to a majority of the outstanding shares entitled to vote. The votes cast on this proposal were as follows:
4,505,398,716 votes
|
FOR the proposal
|
2,019,943 votes
|
AGAINST the proposal
|
154,047 votes
|
ABSTAIN
|
9,947,717 votes
|
Broker Non-Votes
|
2.
Proposal 2 – Proposed Amendment to the Charter to Increase the Authorized Shares. At
the Special Meeting, the Company’s stockholders voted upon and approved the amendment to the Charter to increase the authorized
number of shares of capital stock from 60,000,000 to 110,000,000 shares, and the authorized number of shares of common stock from 50,000,000
to 100,000,000 shares. Of the shares of common stock voted on this proposal, approximately 79.8% voted in favor. Accordingly, approximately
79.8% of the votes represented by the shares of Preferred Stock were counted in favor of the proposal. The votes cast on this proposal
were as follows:
3,603,400,209 votes
|
FOR the proposal
|
854,172,830 votes
|
AGAINST the proposal
|
59,902,382 votes
|
ABSTAIN
|
2 votes
|
Broker Non-Votes
|
3.
Proposal 3 – Adjournment. At the Special Meeting, the Company’s stockholders voted
upon and approved of an adjournment of the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation
and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, Proposal 2. Although the proposal
was rendered moot because Proposal 2 was approved, the votes cast on this proposal were as follows:
13,823,223 votes
|
FOR the proposal
|
3,449,792 votes
|
AGAINST the proposal
|
247,407 votes
|
ABSTAIN
|
2 votes
|
Broker Non-Votes
|
Item 8.01 — Other Events.
On December 8, 2021, the Company issued a press release
announcing the results of the Special Meeting. A copy of such press release is attached to this Current Report on Form 8-K as Exhibit
99.1.
Item 9.01 — Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
Date: December 8,
2021
|
|
OpGen, Inc.
|
|
|
|
|
|
|
By:
|
|
/s/ Oliver Schacht PhD
|
|
|
|
|
Name:
|
|
Oliver
Schacht PhD
|
|
|
|
|
Title:
|
|
Chief
Executive Officer
|
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Jul 2024 to Aug 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Aug 2023 to Aug 2024